Lupus & antiphospholipid syndrome
Pilot Intervention to Improve Medication Adherence Among Patients With Systemic Lupus Erythematosus Using Pharmacy Refill Data
Authors' conclusion
Our intervention showed feasibility, acceptability, and appropriateness and led to a statistically significant improvement in adherence.
Study context
- Population
- Patients with systemic lupus erythematosus (SLE) taking SLE-specific medications, seen by six rheumatologists in routine clinic visits (median age 43, 95% female, 59% racial and ethnic minorities)6 rheumatologists
- Participants
- 130 patients
- Comparison
- Adherence 3 months before vs after the intervention visit
- Outcome
- Feasibility of a pilot intervention using pharmacy refill data to monitor nonadherence and prompt discussions of SLE medications
- Follow-up
- 12 weeks
Methodological detailssingle-group, pre-post comparison, McNemar's test
- Single-group
- Pre-post comparison
- McNemar's test
Main finding
As reported in the abstract
Feasibility, acceptability and appropriateness
Implementation documented in clinic notes
89%
Provider survey feasibility score
4.7/5
Provider survey acceptability score
4.4/5
Provider survey appropriateness score
4.6/5
Further findings
Patients with MPR ≥80% · 3 months before vs after intervention visit · McNemar's test
P = 0.03
Patients' most common reactions to the intervention visit
- Feeling determined
- 32%
- Feeling empowered
- 32%
- Feeling proud
- 19%
Original publication
Pilot Intervention to Improve Medication Adherence Among Patients With Systemic Lupus Erythematosus Using Pharmacy Refill Data. Arthritis Care Res (Hoboken). Published 11 November 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →